CliniMACS Prodigy® Instrument

CliniMACS Prodigy® Instrument

Products & Services

Information

The CliniMACS Prodigy is an automated cell processing instrument designed for the efficient production of GMP-compliant cell and gene therapies. It addresses the manufacturing challenges of autologous and allogeneic therapies by simplifying workflows through automation and integration. The CliniMACS Prodigy streamlines complex processes from cell washing, separation, genetic modification, and expansion to the formulated final cell product. Its versatility allows for standard or custom applications, making it ideal for a wide range of therapies, including T cell, NK cell, and stem cell treatments. Learn more about its full potential from clinical to commercial use.
Miltenyi Biotec71Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to set industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,700 employees across 24 countries.

Log in

See all the content and easy-to-use features by logging in or registering!